cigna and aetna both pointed out in oral arguments what has been referred to in erisa's judicial history as the "panoply" of remedies that calad and davila might have evoked under erisa to prevent the damage suffered, to include appeals of the adverse decisions, judicial injunction to compel utilization review to approve treatment, and a new texas law that allowed for independent arbitration over managed care utilization review decisions based on medical necessity.